Valley National Advisers Inc Madrigal Pharmaceuticals, Inc. Call Options Transaction History
Valley National Advisers Inc
- $613 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MDGL
# of Institutions
365Shares Held
23.2MCall Options Held
979KPut Options Held
432K-
Janus Henderson Group PLC London, X02.21MShares$763 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$726 Million39.89% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$699 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$689 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$683 Million7.8% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.91B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...